Estrogen lowers triglyceride via regulating hepatic APOA5 expression

The Effects of Estrogen on Serum Level and Hepatocyte Expression of PCSK9

(2015) Wen Guo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients

(2014) Sanaa Ouatou et al.   Lipids in Health and Disease

Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents

(2014) Wei-fen Zhu et al.   Lipids in Health and Disease

Cholesterol and atherosclerosis

(2013) Matthias Barton   CURRENT OPINION IN LIPIDOLOGY

GPER Deficiency in Male Mice Results in Insulin Resistance, Dyslipidemia, and a Proinflammatory State

(2013) Geetanjali Sharma et al.   ENDOCRINOLOGY

Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice

(2013) Song-iee Han et al.   HEPATOLOGY

G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-d-glucuronide-induced cholestasis

(2013) Andrés E. Zucchetti et al.   HEPATOLOGY

Role of PPARα and HNF4α in Stress-Mediated Alterations in Lipid Homeostasis

(2013) Maria Konstandi et al.   PLoS One

Apolipoprotein A-V; a potent triglyceride reducer

(2011) Stefan K. Nilsson et al.   ATHEROSCLEROSIS

Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response

(2011) Alvaro Pulchinelli et al.   Lipids in Health and Disease

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

(2010) Christopher T Johansen et al.   NATURE GENETICS

The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women

(2009) Betty Korljan et al.   MEDICAL HYPOTHESES